Funded Tech Companies
CytoSorbents
CytoSorbents is a healthcare services venture, located in Princeton. Investment came from Bridge Bank.
Company Overview
Company Name
CytoSorbents
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
305 College Road East
Princeton, NJ 08540
USA
Princeton, NJ 08540
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries. The company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend and others. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending. Geographically it derives substantial revenue from product sales in Germany.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/29/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Phillip Chan
Chief Financial Officer
Kathleen Bloch
Chief Operating Officer
Vincent Capponi
Company Investors
- Bridge Bank
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs